DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fpmn9t/2016_us_hospital) has announced the addition of the "2016 US Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers" report to their offering.
This new report contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:
- Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years
- Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms
- Volume and sales forecasts for 80 infectious disease tests performed in US hospital laboratories
- Instrumentation technologies and feature comparison of leading analyzers
- Sales and market shares of leading suppliers by test
- Emerging diagnostic technologies and their potential market applications
- Product development opportunities
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies
- Business opportunities and strategic recommendations for suppliers
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreat
For more information visit http://www.researchandmarkets.com/research/fpmn9t/2016_us_hospital
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
